Back
Mercurity Fintech Holding Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
69
MFH
Mercurity Fintech Holding
Last Price:
1.66
Seasonality Move:
-23.5%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
157.97
Seasonality Move:
18.65%
Buy
69
Mercurity Fintech Holding (MFH)
is a Buy
Is Mercurity Fintech Holding a Buy, Sell or Hold?
- The current Mercurity Fintech Holding [MFH] share price is $1.78. The Score for MFH is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- MFH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $157.96. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MFH Stock Price Chart
What is Mercurity Fintech Holding's stock price today?
-
The Mercurity Fintech Holding share price today is $1.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MFH is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $157.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
MFH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 59.77 | Buy |
| Chaikin Money Flow: | 19742 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.43 - 1.67) | Buy |
| Bollinger Bands (100): | (1.19 - 2.49) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.07 | Buy |
| Relative Strength Index (14 RSI): | 68.93 | Buy |
| Chaikin Money Flow: | 909555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.85 - 144.93) | Buy |
| Bollinger Bands (100): | (118.68 - 136.96) | Buy |
MFH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.53 | Buy |
| 20-day SMA: | 1.57 | Buy |
| 50-day SMA: | 1.49 | Buy |
| 200-day SMA: | 1.69 | Buy |
| 8-day EMA: | 1.58 | Buy |
| 20-day EMA: | 1.56 | Buy |
| 50-day EMA: | 1.57 | Buy |
| 200-day EMA: | 1.69 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.42 | Buy |
| 20-day SMA: | 131.3 | Buy |
| 50-day SMA: | 128.76 | Buy |
| 200-day SMA: | 115.64 | Buy |
| 8-day EMA: | 148.13 | Buy |
| 20-day EMA: | 137 | Buy |
| 50-day EMA: | 130.51 | Buy |
| 200-day EMA: | 121.04 | Buy |
Mercurity Fintech Holding Earnings Growth & MFH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Mercurity Fintech Holding Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||